No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
430 |
4. Check minimum number of eventsNone |
430 |
5. Include endpointsNone |
430 |
6. Filter based on genotype QC (FinnGen only) |
430 |
Control definitions (FinnGen only)
- Control exclude
- M13_DORSOPATHY
Extra metadata
- Level in the ICD hierarchy
- 4
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- M40-M43
- Name in latin
- Osteochondrosis spinalis
Similar endpoints
↥List of similar endpoints to
Spinal osteochondrosis
based on the number of shared cases.
Similar with more cases:
- Deforming dorsopathies
- Dorsopathies
- Diseases of the musculoskeletal system and connective tissue
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4271 | 1626 | 2630 |
| Only index persons | 4030 | 1537 | 2493 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.05 | 0.07 |
| Only index persons | 0.08 | 0.06 | 0.10 |
| Median age at first event (years) | |||
| Whole population | 35.52 | 48.47 | 27.38 |
| Only index persons | 33.50 | 46.39 | 25.56 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 430 | 198 | 232 |
| Unadjusted period prevalence (%) | 0.09 | 0.07 | 0.10 |
| Median age at first event (years) | 40.21 | 43.12 | 37.74 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 396
- Matched controls
- 3960
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
M42.0
ICD-10 Finland
Juvenile osteochondrosis of spine
+∞
275.3
231
*
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
76.6
99.7
111
20
M48.0
ICD-10 Finland
Spinal stenosis
162.1
96.1
98
8
M42.1
ICD-10 Finland
Adult osteochondrosis of spine
+∞
87.8
81
*
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
79.6
64.9
72
11
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
43.7
60.9
75
21
N03AX16
ATC
pregabalin; oral
8.2
58.5
151
278
M54.5
ICD-10 Finland
Low back pain
6.6
57.4
184
459
M54.9
ICD-10 Finland
Dorsalgia, unspecified
17.0
56.6
93
70
N03AX12
ATC
gabapentin; oral
11.2
52.2
105
123
M42.9
ICD-10 Finland
Spinal osteochondrosis, unspecified
+∞
51.2
48
*
N02AX02
ATC
tramadol; systemic, rectal
5.2
49.4
216
746
ABC36
NOMESCO Finland
Decompression of lumbar nerve roots
190.1
49.1
50
*
7320A
ICD-9 Finland
Osteochondropathies, Juvenile osteochondrosis of spine[MORBUS SCHEUERMANN]
+∞
47.9
45
*
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
265.8
47.1
47
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
17.9
38.0
60
39
M54.4
ICD-10 Finland
Lumbago with sciatica
8.7
35.9
82
115
M03BC01
ATC
orphenadrine (citrate); systemic
4.5
31.6
132
393
M47.82
ICD-10 Finland
Other spondylosis, cervical region
76.4
31.4
35
5
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
9.4
31.2
67
84
M03BX02
ATC
tizanidine; oral
3.3
28.2
269
1534
M54.6
ICD-10 Finland
Pain in thoracic spine
10.5
28.1
56
61
N06AX21
ATC
duloxetine; oral
7.2
27.5
70
114
L03
ICPC
Low back symptom/complaint
4.4
27.3
115
339
NA7EA
NOMESCO Finland
Scoliosis X-ray examination
144.5
25.9
27
*
M43.1
ICD-10 Finland
Spondylolisthesis
75.0
25.1
28
*
M47.9
ICD-10 Finland
Spondylosis, unspecified
96.4
25.0
27
*
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
3.1
24.8
201
984
L02
ICPC
Back symptom/complaint
6.9
24.8
65
110
N06AA09
ATC
amitriptyline; systemic
7.6
23.2
56
84
M47.80
ICD-10 Finland
Other spondylosis, multiple sites in spine
31.1
22.2
29
10
NAG62
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, 2-3 vertebraea
+∞
22.1
21
*
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
121.8
21.8
23
*
M54.3
ICD-10 Finland
Sciatica
18.8
21.7
33
19
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
15.9
21.6
35
24
M01AH05
ATC
etoricoxib; oral
2.8
21.5
243
1427
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
34.6
20.4
26
8
M53.1
ICD-10 Finland
Cervicobrachial syndrome
6.3
19.6
54
97
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
33.2
19.5
25
8
M01AH01
ATC
celecoxib; oral (coxibs)
4.1
19.4
83
241
N06AX11
ATC
mirtazapine; oral
2.9
18.4
146
669
A02BC02
ATC
pantoprazole; systemic
2.6
17.9
250
1583
NAG40
NOMESCO Finland
Anterior fusion of cervical spine without fixation
+∞
17.8
17
*
M79.6
ICD-10 Finland
Pain in limb
2.8
17.8
146
684
ABC16
NOMESCO Finland
Microsurgical excision of lumbar intervertebral disc displacement
188.1
17.7
18
*
M50.3
ICD-10 Finland
Other cervical disc degeneration
188.1
17.7
18
*
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
18.0
17.6
27
16
N02BE01
ATC
paracetamol; systemic, rectal
3.2
17.6
340
2594
M01AH02
ATC
rofecoxib; oral
4.5
17.5
65
164
M54.2
ICD-10 Finland
Cervicalgia
8.6
17.5
38
48
R51.80
ICD-10 Finland
Headache
3.8
17.1
78
238
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
3.0
16.5
114
471
M54.1
ICD-10 Finland
Radiculopathy
31.6
16.3
21
7
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
16.2
149
737
A02BC05
ATC
esomeprazole; systemic
2.5
15.8
163
856
M40.2
ICD-10 Finland
Other and unspecified kyphosis
+∞
15.7
15
*
M01AE03
ATC
ketoprofen; systemic, rectal
2.6
15.7
154
788
N02AJ06
ATC
codeine and paracetamol; systemic
2.6
15.6
154
790
Z01.8
ICD-10 Finland
Other specified special examinations
3.1
15.4
99
390
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
3.9
15.3
67
197
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.8
15.3
118
521
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
59.0
14.9
17
*
ABC56
NOMESCO Finland
Decompression of lumbar spinal canal and nerve roots
+∞
14.7
14
*
N06AX16
ATC
venlafaxine; oral
3.5
14.4
73
242
R03AC02
ATC
salbutamol; inhalant
2.3
13.8
209
1305
M01AB05
ATC
diclofenac; systemic, rectal
2.3
13.6
257
1773
R53
ICD-10 Finland
Malaise and fatigue
2.9
13.2
88
351
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
23.5
13.0
18
8
N06CA01
ATC
amitriptyline and psycholeptics; systemic
4.2
12.9
50
131
M01AE02
ATC
naproxen; oral, rectal
2.2
12.9
225
1484
ABC26
NOMESCO Finland
Open discectomy of lumbar spine
+∞
12.6
12
*
A02BC03
ATC
lansoprazole; oral
2.6
12.6
108
500
G56.0
ICD-10 Finland
Carpal tunnel syndrome
3.8
12.5
54
156
M45
ICD-10 Finland
Ankylosing spondylitis
134.1
12.5
13
*
N05CF01
ATC
zopiclone; oral
2.4
12.4
126
639
M03BC51
ATC
orphenadrine, combinations; systemic
2.5
12.4
114
549
R06.0
ICD-10 Finland
Dyspnoea
2.6
12.2
98
438
SPAT1097
SPAT
Recording of ECG
3.4
12.1
62
207
N05AH04
ATC
quetiapine; oral
2.8
12.0
85
352
M41.9
ICD-10 Finland
Scoliosis, unspecified
67.0
11.7
13
*
H02AB06
ATC
prednisolone; systemic
2.2
11.7
172
1036
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
23.7
11.7
16
7
NA1AA
NOMESCO Finland
Cervical spine X-ray examination without contrast
10.5
11.6
22
22
M25.5
ICD-10 Finland
Pain in joint
2.5
11.5
109
530
NAG53
NOMESCO Finland
Posterior or lateral fusion of thoracic spine with fixation, more than 3 vertebraea
+∞
11.5
11
*
M43.0
ICD-10 Finland
Spondylolysis
123.5
11.5
12
*
A02BC01
ATC
omeprazole; systemic
2.5
11.4
104
496
M01AB55
ATC
diclofenac, combinations; oral
5.4
11.4
34
68
Z50.1
ICD-10 Finland
Other physical therapy
5.3
11.2
34
69
J01AA02
ATC
doxycycline; systemic
2.2
11.2
292
2225
G44.2
ICD-10 Finland
Tension-type headache
3.4
11.2
56
183
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.5
11.0
39
94
C07AA05
ATC
propranolol; systemic
2.6
10.7
88
394
G55.1*M51.1
ICD-10 Finland
Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions
61.7
10.7
12
*
N06AB04
ATC
citalopram; systemic
2.6
10.7
86
383
R52.2
ICD-10 Finland
Other chronic pain
10.5
10.6
20
20
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
14.7
10.6
17
12
M47.1
ICD-10 Finland
Other spondylosis with myelopathy
+∞
10.5
10
*
G55.2*M47.9
ICD-10 Finland
Nerve root and plexus compressions in spondylosis
+∞
10.5
10
*
L86
ICPC
Back syndrome with radiating pain
7.4
10.4
24
34
M01AX17
ATC
nimesulide; oral
2.5
10.4
92
430
G47.3
ICD-10 Finland
Sleep apnoea
2.4
10.3
95
452
UJF32
NOMESCO Finland
Coloscopy
2.4
10.2
97
468
SPAT1256
SPAT
Intramuscular and subcutaneous injection
2.1
10.2
158
957
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
7.6
10.1
23
32
SPAT1301
SPAT
No procedures
2.2
10.1
125
687
NA1EA
NOMESCO Finland
Cervical spine X-ray examination with flexion
41.2
10.0
12
*
N02AA05
ATC
oxycodone; systemic
3.1
10.0
56
198
M79.0
ICD-10 Finland
Rheumatism, unspecified
9.9
9.9
19
20
M75.1
ICD-10 Finland
Rotator cuff syndrome
2.5
9.6
85
396
R07.4
ICD-10 Finland
Chest pain, unspecified
2.3
9.5
97
487
J01DB01
ATC
cefalexin; oral
2.2
9.5
320
2606
NA6BG
NOMESCO Finland
Sacro-iliac joint MRI examination with high intensity magnet
30.8
9.5
12
*
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.0
9.4
200
1358
7227C
ICD-9 Finland
Intervertebral disk disorders, Intervertebral disk disorder with myelopathy[SYNDROMA ISCHIADICUM]
+∞
9.4
9
*
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
2.3
9.4
100
511
N04BC05
ATC
pramipexole; oral
5.0
9.2
29
62
M01AC06
ATC
meloxicam; systemic, rectal
2.1
9.2
127
726
J31.0
ICD-10 Finland
Chronic rhinitis
4.0
9.1
36
97
A01
ICPC
Pain general/multiple sites
4.2
9.1
34
87
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
4.2
9.1
34
87
M79.1
ICD-10 Finland
Myalgia
3.0
9.1
55
204
R42
ICD-10 Finland
Dizziness and giddiness
2.5
9.0
78
357
M35.7
ICD-10 Finland
Hypermobility syndrome
24.7
9.0
12
5
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.1
8.9
124
711
R01AD08
ATC
fluticasone; nasal
2.1
8.9
115
639
N05BA12
ATC
alprazolam; oral
3.3
8.8
44
144
L28
ICPC
Limited function/disability (L)
2.9
8.8
55
210
J01DA01
ATC
[U] cefalexin; systemic
1.9
8.8
233
1700
M54
ICD-10 Finland
Dorsalgia
3.2
8.7
45
151
M51.9
ICD-10 Finland
Intervertebral disc disorder, unspecified
51.1
8.7
10
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.4
8.7
82
395
C07AB07
ATC
bisoprolol; oral
1.9
8.6
156
991
M53.0
ICD-10 Finland
Cervicocranial syndrome
3.9
8.6
35
97
WX110
NOMESCO Finland
Local anesthesy
1.9
8.6
272
2108
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.1
8.6
113
630
N06AX03
ATC
mianserin; oral
6.2
8.6
22
37
N05CD07
ATC
temazepam; oral
3.1
8.5
48
170
A02BA02
ATC
ranitidine; systemic
2.6
8.5
66
287
M41.1
ICD-10 Finland
Juvenile idiopathic scoliosis
91.9
8.4
9
*
NAG63
NOMESCO Finland
Posterior fusion of lumbar spine with fixation, more than 3 vertebraea
+∞
8.4
8
*
7245A
ICD-9 Finland
Other and unspecified disorders of back, Backache, unspecified
+∞
8.4
8
*
H05BA01
ATC
calcitonin (salmon synthetic); nasal, parenteral
11.1
8.4
15
14
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
3.2
8.4
44
150
EBA00
NOMESCO Finland
Extraction of tooth
2.0
8.3
135
820
N06AB10
ATC
escitalopram; oral
2.3
8.3
83
409
R4110
NOMESCO Finland
Physiotherapy
2.2
8.2
97
518
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.9
8.2
209
1491
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
7.1
8.2
19
28
J01.0
ICD-10 Finland
Acute maxillary sinusitis
2.3
8.2
83
414
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.9
8.1
186
1275
M70.6
ICD-10 Finland
Trochanteric bursitis
3.5
8.0
37
114
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
8.0
151
966
M79.7
ICD-10 Finland
Fibromyalgia
8.0
8.0
17
22
N02AJ13
ATC
tramadol and paracetamol; systemic
13.4
7.9
13
10
N05BA01
ATC
diazepam; systemic, rectal
2.7
7.9
54
218
C03CA01
ATC
furosemide; systemic
2.2
7.9
87
449
L01
ICPC
Neck symptom/complaint
2.8
7.9
52
203
M19.0
ICD-10 Finland
Primary arthrosis of other joints
3.3
7.8
38
122
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.6
7.8
61
262
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
7.8
55
224
M47.81
ICD-10 Finland
Other spondylosis, occipito-atlanto-axial region
45.9
7.7
9
*
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.8
7.7
221
1625
N03AE01
ATC
clonazepam; systemic
3.8
7.7
31
86
SPAT1263
SPAT
Sampling
1.9
7.7
162
1073
WZB00
NOMESCO Finland
Telephone receipt or other advice
2.0
7.6
113
660
UJD02
NOMESCO Finland
Gastroscopy
4.8
7.5
24
53
N05BA04
ATC
oxazepam; oral
2.1
7.5
92
497
M41.2
ICD-10 Finland
Other idiopathic scoliosis
81.6
7.4
8
*
M46.9
ICD-10 Finland
Inflammatory spondylopathy, unspecified
81.6
7.4
8
*
G43.9
ICD-10 Finland
Migraine, unspecified
4.2
7.4
27
68
J45.9
ICD-10 Finland
Asthma, unspecified
2.4
7.4
64
293
R1250
NOMESCO Finland
Evaluation of functional capability
8.6
7.4
15
18
N05CF02
ATC
zolpidem; oral
2.4
7.4
66
306
M51.8
ICD-10 Finland
Other specified intervertebral disc disorders
+∞
7.3
7
*
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
+∞
7.3
7
*
M40.1
ICD-10 Finland
Other secondary kyphosis
+∞
7.3
7
*
G55.1*M51.9
ICD-10 Finland
Nerve root and plexus compressions in intervertebral disc disorders (M50-M51+)
+∞
7.3
7
*
NAG65
NOMESCO Finland
Anterior and posterior fusion of lumbar spine
+∞
7.3
7
*
A07EC01
ATC
sulfasalazine; oral, rectal
3.5
7.3
33
101
SPAT1222
SPAT
Counselling/guidance promoting independent living
2.6
7.2
53
223
M54.0
ICD-10 Finland
Panniculitis affecting regions of neck and back
30.6
7.2
9
*
SPAT1153
SPAT
Removal of sutures
2.0
7.2
108
630
H01
ICPC
Ear pain/earache
2.9
7.1
42
155
M24.4
ICD-10 Finland
Recurrent dislocation and subluxation of joint
12.3
7.1
12
10
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.4
7.1
63
293
M01AB08
ATC
etodolac; oral
3.8
7.0
28
77
K02.1
ICD-10 Finland
Caries of dentine
1.8
7.0
225
1695
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
3.1
6.9
37
128
SPAT1212
SPAT
Extensive examination of musculoskeletal system
3.4
6.9
32
100
J01FA10
ATC
azithromycin; systemic
1.7
6.8
222
1671
R52.1
ICD-10 Finland
Chronic intractable pain
40.8
6.8
8
*
R55
ICD-10 Finland
Syncope and collapse
2.8
6.7
42
159
I25.1
ICD-10 Finland
Atherosclerotic heart disease
2.3
6.7
65
316
L08
ICPC
Shoulder symptom/complaint
2.3
6.6
62
296
SAA01
NOMESCO Finland
Simple examination of mouth
1.8
6.6
269
2160
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
2.8
6.6
40
151
SFA40
NOMESCO Finland
Replacement of krone of tooth
2.2
6.6
74
381
R03AK06
ATC
salmeterol and fluticasone; inhalant
2.5
6.6
52
228
SPAT1310
SPAT
Counselling related to known health issue
1.9
6.6
115
708
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.0
6.6
99
575
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.7
6.5
201
1483
ZZH21
NOMESCO Finland
Graft of patients own bone, small pieces
7.6
6.5
14
19
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.0
6.4
36
126
ABD32
NOMESCO Finland
Implantation of temporary spinal stimulation device
70.9
6.4
7
*
N06AB03
ATC
fluoxetine; oral
2.6
6.4
47
195
M77.1
ICD-10 Finland
Lateral epicondylitis
3.2
6.4
32
106
WX408
NOMESCO Finland
General anesthesy, balanced
1.9
6.4
101
598
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
3.1
6.4
34
118
M16.1
ICD-10 Finland
Other primary coxarthrosis
3.0
6.4
36
128
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
3.0
6.4
36
128
M15.9
ICD-10 Finland
Polyarthrosis, unspecified
5.7
6.4
17
31
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.9
6.3
99
584
R52.9
ICD-10 Finland
Pain, unspecified
3.1
6.3
33
113
J01CA04
ATC
amoxicillin; systemic
1.8
6.3
311
2631
F34.1
ICD-10 Finland
Dysthymia
4.3
6.3
22
54
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
4.1
6.3
23
59
205
Kela drug reimbursment
Chronic hypertension
2.0
6.3
85
473
M76.8
ICD-10 Finland
Other enthesopathies of lower limb, excluding foot
18.4
6.3
9
5
R01AD09
ATC
mometasone; nasal
1.7
6.3
164
1147
M53.2
ICD-10 Finland
Spinal instabilities
+∞
6.3
6
*
7225A
ICD-9 Finland
Intervertebral disk disorders, Degeneration of thoracic or lumbar intervertebral disk[DEGENERATIO DISCI INTERVERTEBRALIS THORAC SEU LUMB]
+∞
6.3
6
*
M96.1
ICD-10 Finland
Postlaminectomy syndrome, not elsewhere classified
+∞
6.3
6
*
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
+∞
6.3
6
*
72870
ICD-8 Finland
Vertebrogenic pain syndrome, Lumbalgia
+∞
6.3
6
*
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
6.2
54
246
N06AX12
ATC
bupropion; oral
3.2
6.2
31
103
SPAT1254
SPAT
Administration of medicine
2.3
6.2
56
261
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
3.1
6.1
32
110
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
3.3
6.1
29
93
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.8
6.1
39
151
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.7
6.1
143
967
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
4.7
6.1
19
42
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
5.7
6.1
16
29
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
156
807
2.46
16.86
2.4
2.0
u/l
212.0
224.9
0.11
147
761
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
109
484
2.68
16.12
1.4
1.2
iu/ml
20.2
28.9
0.62
31
157
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
330
2404
2.60
15.95
4.3
3.6
pmol/l
14.9
14.7
0.74
307
2188
(3013707) Erythrocyte sedimentation rate by Westergren method
317
2286
2.47
15.33
5.6
3.4
mm/h
10.9
10.5
0.22
303
2092
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
100
447
2.61
14.46
1.3
1.2
u/ml
2.9
8.1
1.35
42
171
(3019198) Lymphocytes [#/volume] in Blood
242
1608
2.15
13.52
7.4
5.7
e9/l
1.9
2.0
0.11
225
1432
(3006315) Basophils [#/volume] in Blood
235
1560
2.12
12.98
7.4
5.7
e9/l
0.0
0.0
1.23
211
1363
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
154
871
2.20
12.88
2.8
2.4
u/l
50.8
56.5
1.76
143
809
(3001604) Monocytes [#/volume] in Blood
234
1554
2.11
12.87
7.5
5.7
e9/l
0.6
0.6
0.09
211
1353
(3013115) Eosinophils [#/volume] in Blood
240
1612
2.11
12.77
8.6
6.2
e9/l
0.2
0.2
1.16
221
1432
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
111
552
2.36
12.60
1.8
1.7
pmol/l
408.8
8474996.3
0.50
94
472
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
213
1388
2.06
12.08
7.4
6.5
mmol/l
1.2
1.2
1.22
191
1182
(3031040) Bacteria [#/volume] in Urine by Automated count
269
1913
2.08
11.95
5.8
3.6
e6/l
88.9
836.2
—
7
30
(3000850) Epithelial cells [#/volume] in Urine
110
558
2.31
11.85
3.0
2.5
e6/l
5.7
5.4
0.08
98
490
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
179
1101
2.07
11.82
2.2
1.7
pmol/l
94.8
96.8
0.20
95
569
(3019309) Folate [Moles/volume] in Red Blood Cells
93
442
2.41
11.61
1.9
1.6
nmol/l
1019.2
1139.3
0.75
74
337
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
311
2353
2.16
11.49
8.3
7.0
u/l
75.1
77.5
0.70
296
2204
(3013826) Glucose [Moles/volume] in Serum or Plasma
248
1730
2.02
11.41
5.2
4.5
mmol/l
6.5
6.7
0.49
234
1598
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
171
1049
2.05
11.25
4.1
3.2
ng/l
32.2
42.0
0.53
116
663
(3037467) Urinalysis macro (dipstick) panel - Urine
284
2086
2.06
11.23
5.9
3.6
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
122
660
2.18
11.17
2.5
2.0
mg/l
2.7
3.0
0.84
107
572
(3009261) Glucose [Presence] in Urine by Test strip
218
1466
1.99
10.99
4.0
3.0
estimate
0.0
0.0
0.50
31
257
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
226
1539
1.99
10.99
5.7
6.3
umol/l
10.1
11.9
1.91
216
1470
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
366
2984
2.52
10.93
5.4
4.2
mu/l
1.8
2.3
0.62
347
2736
(3032080) INR in Blood by Coagulation assay
178
1117
2.01
10.92
8.3
7.7
inr
1.3
1.2
0.62
41
337
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
166
1019
2.02
10.81
3.5
3.0
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
187
1199
1.99
10.75
5.4
4.7
g/l
36.7
36.3
0.39
174
1120
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
36
106
3.62
10.67
2.9
2.4
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
215
1450
1.97
10.64
4.0
3.0
estimate
0.0
0.0
0.00
30
276
(42870588) Differential panel, method unspecified - Blood
162
994
2.01
10.50
8.0
5.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
394
3350
3.10
10.43
19.5
11.0
mg/l
17.8
24.3
5.07
328
2555
(3021601) Nitrite [Presence] in Urine by Test strip
215
1460
1.95
10.33
5.8
4.2
estimate
0.0
0.0
0.00
29
277
(3002030) Lymphocytes/100 leukocytes in Blood
223
1537
1.94
10.21
8.3
5.6
%
29.4
28.5
0.70
213
1450
(3013650) Neutrophils [#/volume] in Blood by Automated count
251
1809
1.93
9.95
10.8
9.3
e9/l
4.2
4.0
0.56
227
1585
(3008898) HLA-B27 [Presence]
36
112
3.42
9.82
1.1
1.1
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
71
323
2.44
9.66
2.5
1.6
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
215
1485
1.90
9.58
8.7
5.8
%
8.0
8.6
2.47
205
1408
(3006504) Eosinophils/100 leukocytes in Blood
214
1476
1.90
9.58
8.2
5.5
%
3.0
2.8
0.36
203
1389
(3018010) Neutrophils/100 leukocytes in Blood
217
1513
1.88
9.30
8.0
5.4
%
56.6
56.6
0.01
209
1438
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
116
657
2.05
9.21
1.7
1.6
mg/l
0.9
1.1
0.51
88
483
(3022948) Iron [Moles/volume] in Serum or Plasma
83
413
2.25
9.18
2.4
2.3
umol/l
13.4
14.0
0.29
77
380
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
182
1210
1.87
8.97
2.8
2.1
nmol/l
73.4
75.1
0.39
174
1103
(3022096) Basophils/100 leukocytes in Blood
206
1427
1.85
8.89
8.3
5.6
%
0.7
0.7
0.13
194
1343
(3018095) Leukocytes [#/volume] in Urine
160
1024
1.90
8.85
4.2
3.4
e6/l
94.0
150.6
0.29
122
686
(3026008) Bacteria identified in Urine by Culture
128
761
1.97
8.82
4.1
2.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
140
866
1.91
8.54
3.5
3.0
e6/l
17.8
88.2
2.70
112
645
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
166
1087
1.86
8.47
4.3
3.4
u/l
30.5
33.1
0.68
150
1039
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
121
715
1.96
8.44
3.1
3.3
ng/l
2218.3
1366.6
0.52
107
594
(3019150) Specific gravity of Urine by Refractometry
109
622
2.01
8.40
4.3
3.2
kg/l
1.0
1.0
0.06
14
81
(40761511) CBC panel - Blood by Automated count
406
3592
3.33
8.39
17.3
10.4
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
197
1365
1.82
8.34
3.3
2.5
ug/l
109.1
121.5
0.50
186
1271
(3030467) Casts [#/volume] in Urine by Automated count
127
773
1.91
8.07
3.1
2.9
e6/l
0.5
0.4
0.16
102
558
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
183
1251
1.81
8.02
5.7
5.8
mmol/l
1.2
1.2
0.01
172
1144
(3026493) Urate [Moles/volume] in Serum or Plasma
126
768
1.91
7.96
3.3
2.4
umol/l
6683.4
5508.8
0.09
113
689
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
196
1377
1.78
7.76
5.2
3.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
96
539
2.01
7.68
4.9
3.1
ng/l
219.1
568.9
1.07
67
395
(4010399)
48
203
2.54
7.59
1.4
1.3
—
—
—
0
0
(44813793)
11
15
7.50
7.58
1.0
1.0
—
—
—
0
0
(3013512) EKG study
128
795
1.87
7.58
4.1
3.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
385
3364
2.38
7.30
21.0
12.8
mmol/l
139.6
139.7
0.26
377
3252
(3037522) Nuclear Ab [Titer] in Serum
75
393
2.10
7.21
1.5
1.4
titre
1097.1
424.8
0.76
14
87
(3023103) Potassium [Moles/volume] in Serum or Plasma
385
3377
2.34
7.00
21.3
12.9
mmol/l
3.9
4.0
0.59
377
3257
(3002385) Erythrocyte distribution width [Ratio]
346
2923
1.94
6.91
21.8
14.2
%
13.5
13.5
0.06
339
2871
(3012544) pH of Venous blood
54
252
2.31
6.89
2.8
3.3
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
201
1457
1.71
6.88
10.3
8.1
e9/l
0.0
0.0
0.57
176
1203
(36304419) Bacteria [Presence] in Urine
121
759
1.83
6.85
2.9
2.8
—
—
—
0
0
(3044889) 12 lead EKG panel
279
2222
1.73
6.66
4.1
3.3
—
—
—
0
0
(3026782) Osmolality of Urine
94
550
1.91
6.60
2.9
2.6
mosm/kgh2o
526.9
578.2
1.32
77
465
(3003458) Phosphate [Moles/volume] in Serum or Plasma
70
370
2.07
6.55
4.9
5.7
mmol/l
1.0
1.0
0.13
63
348
(3020630) Protein [Mass/volume] in Serum or Plasma
44
192
2.44
6.52
1.4
2.7
g/l
67.2
66.8
0.13
37
180
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
80
445
1.98
6.51
2.6
2.6
e6/l
1.2
1.0
0.26
52
241
(3021960) Folate [Moles/volume] in Serum or Plasma
101
608
1.86
6.49
1.6
1.4
nmol/l
18.5
20.7
0.85
89
526
(3015377) Calcium [Moles/volume] in Serum or Plasma
141
944
1.73
6.32
2.7
3.3
mmol/l
2.3
2.4
0.33
122
847
(3017181) Myelocytes/100 leukocytes in Blood
51
242
2.26
6.26
2.7
4.1
%
0.9
0.7
0.11
14
73
(3000330) Specific gravity of Urine by Test strip
33
131
2.65
5.94
3.2
3.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
51
248
2.20
5.90
2.7
3.3
mmol/l
2.2
1.6
0.50
41
196
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
350
3019
1.86
5.86
6.3
5.0
mmol/mol
39.5
39.3
0.09
328
2829
(3023368) Bacteria identified in Blood by Culture
113
725
1.76
5.82
5.4
3.9
—
—
—
0
0
(3018418) pH of Serum or Plasma
126
834
1.72
5.82
3.4
3.6
ph
7.4
7.4
0.10
19
151
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
75
424
1.93
5.79
2.4
1.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
70
387
1.97
5.77
2.4
2.3
g/l
2.4
2.4
0.25
64
359
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
57
293
2.09
5.73
2.8
4.7
u/l
225.9
234.8
0.29
51
285
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
161
1142
1.66
5.71
4.2
3.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
402
3653
2.54
5.70
12.2
8.7
u/l
28.6
28.6
0.02
392
3519
(3022217) INR in Platelet poor plasma by Coagulation assay
60
316
2.04
5.66
18.0
20.1
inr
1.4
1.3
—
10
41
(3042936) Bacteria identified in Isolate by Culture
73
413
1.92
5.62
2.6
2.1
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
289
2379
1.66
5.56
3.7
2.8
u/l
51.7
47.6
0.27
266
2239
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
13
29
4.59
5.54
1.5
1.6
nmol/l
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
47
229
2.18
5.41
2.6
4.2
%
0.3
0.1
0.52
14
68
(3048689) Calprotectin [Mass/mass] in Stool
68
381
1.93
5.38
2.3
2.4
ug/g
163.1
118.6
0.36
55
301
(3027945) Reticulocytes/100 erythrocytes in Blood
55
288
2.04
5.27
3.1
3.1
%
1.9
1.7
0.52
47
269
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
55
288
2.04
5.27
2.5
1.7
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
59
3.32
5.23
1.2
1.1
u/ml
0.3
3.0
0.65
12
23
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
65
363
1.93
5.19
2.6
2.3
%
22.6
23.8
0.27
52
322
(3002179) Metamyelocytes/100 leukocytes in Blood
45
220
2.17
5.14
2.5
4.0
%
0.4
0.4
—
8
50
(3013139) Helicobacter pylori Ag [Presence] in Stool
38
173
2.31
5.14
1.2
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
13
31
4.29
5.12
1.6
1.6
—
0.6
—
0
5
(3019060) Gas panel - Arterial blood
36
161
2.35
5.07
6.5
5.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
22
77
2.96
5.00
2.8
4.0
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
419
3920
3.69
5.00
27.2
16.3
e9/l
254.6
248.5
1.13
412
3815
(3026361) Erythrocytes [#/volume] in Blood
419
3924
3.65
4.91
27.1
16.3
e12/l
4.6
4.6
0.60
413
3811
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
20
67
3.08
4.89
1.4
1.2
—
—
—
0
0
(3022621) pH of Urine by Test strip
36
164
2.30
4.87
3.4
2.3
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
14
37
3.88
4.85
1.6
1.4
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
419
3927
3.62
4.84
27.3
16.3
e9/l
6.8
6.6
1.20
413
3809
(40760892) CBC W Ordered Manual Differential panel - Blood
110
737
1.66
4.74
4.2
4.5
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
42
207
2.14
4.71
1.7
1.5
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
35
162
2.26
4.57
1.6
2.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
15
44
3.50
4.50
1.1
1.1
u/ml
3.6
2.0
—
8
18
(3041096) Erythrocytes [Presence] in Urine by Automated
123
859
1.60
4.47
3.3
2.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
363
3241
1.77
4.46
5.1
3.8
mmol/l
5.9
5.9
0.25
343
2969
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
36
172
2.19
4.37
3.4
3.5
pmol/l
4.4
4.6
0.40
29
151
(3023430) Cat dander IgE Ab [Units/volume] in Serum
14
40
3.58
4.37
1.1
1.1
u/ml
31.3
2.6
—
8
17
(3004119) Hemoglobin [Mass/volume] in Venous blood
35
166
2.21
4.33
2.3
2.6
g/l
130.9
131.3
0.03
35
161
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
53
294
1.92
4.32
2.5
1.7
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
38
187
2.13
4.29
1.1
1.2
—
58.4
—
0
13
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
17
56
3.12
4.29
1.6
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
132
947
1.57
4.25
3.3
3.3
mmol/l
7.5
8.5
1.35
118
809
(3033658) Prothrombin time (PT) actual/Normal
111
765
1.61
4.23
3.5
3.6
%
92.7
91.6
0.17
104
760
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
363
3254
1.74
4.23
4.1
3.5
mmol/l
1.4
1.3
1.17
341
3036
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
101
684
1.62
4.13
2.1
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
21
81
2.67
4.03
1.4
1.9
g/l
9.8
10.2
0.24
16
72
(3010726) Horse dander IgE Ab [Units/volume] in Serum
16
53
3.10
4.00
1.1
1.1
u/ml
1.8
4.3
—
6
16
(3044640) Blood type and Crossmatch panel - Blood
130
941
1.55
3.99
2.7
2.1
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
42
221
2.00
3.99
2.5
4.2
%
0.0
0.2
—
10
56
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
89
2.55
3.86
1.4
2.0
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
89
2.55
3.86
1.4
2.0
g/l
3.5
3.7
0.39
12
64
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
22
89
2.55
3.86
1.4
2.0
g/l
6.8
7.1
0.25
12
69
(3009542) Hematocrit [Volume Fraction] of Blood
363
3276
1.69
3.85
20.4
12.1
%
38.1
41.0
3.53
244
2588
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
372
3380
1.75
3.84
4.7
3.8
mmol/l
4.7
4.7
0.10
354
3161
(3020682) Albumin/Creatinine [Ratio] in Urine
123
889
1.54
3.77
4.2
4.1
mg/mmol
10.2
10.2
0.00
74
583
(3012516) Albumin [Mass/volume] in Urine
116
830
1.54
3.72
3.3
3.3
mg/l
696.6
224.8
0.35
68
550
(3044941) Cell count panel - Synovial fluid
13
40
3.32
3.65
1.8
1.2
—
—
—
0
0
(3000492) Spirometry study
57
344
1.76
3.56
1.4
1.4
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
8
13
6.25
3.51
1.3
1.3
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
30
146
2.13
3.51
9.4
10.5
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
12
36
3.40
3.50
1.2
2.1
—
—
—
0
0
(3041354) Potassium [Moles/volume] in Venous blood
12
36
3.40
3.50
1.2
2.1
mmol/l
4.2
4.0
0.57
12
36
(3035285) Chloride [Moles/volume] in Venous blood
12
36
3.40
3.50
1.2
2.1
mmol/l
106.1
105.4
0.22
12
36
(3003396) Base excess in Arterial blood by calculation
53
315
1.78
3.49
6.4
8.6
mmol/l
1.6
0.9
1.02
41
258
(3052851) Hemolysis interference index of Serum or Plasma
21
89
2.43
3.37
2.6
3.9
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
58
358
1.72
3.36
1.2
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
368
3365
1.65
3.31
4.6
3.8
mmol/l
1.4
1.4
1.82
349
3140
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
31
157
2.05
3.29
3.1
3.2
mmol/l
1.2
2.2
0.66
24
117
(3044290) Cell count panel - Cerebral spinal fluid
15
54
2.84
3.28
1.0
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
23
103
2.30
3.28
1.5
1.3
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
100
711
1.53
3.27
2.6
2.1
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
75
499
1.61
3.26
1.9
2.0
%
1.5
1.4
0.53
58
464
(3003327) Ova and parasites identified in Stool by Light microscopy
22
98
2.31
3.18
1.5
1.6
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
373
3433
1.65
3.14
5.2
4.2
mmol/l
2.8
2.8
0.12
348
3194
(3007164) IgA [Mass/volume] in Serum or Plasma
92
648
1.53
3.13
1.6
1.4
g/l
2.1
2.3
1.53
61
412
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
67
439
1.62
3.10
2.9
2.7
e6/l
2.1
2.4
0.09
39
235
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
10
29
3.51
3.06
1.8
1.7
—
—
—
0
0
(40758558) Short blood count panel - Blood
107
782
1.49
3.05
9.0
6.7
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
88
617
1.54
3.05
4.5
3.0
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
134
1026
1.44
3.01
4.4
4.0
ug/l
1.4
2.2
1.57
126
928
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
57
362
1.66
2.98
1.8
2.5
umol/l
8.9
9.5
0.06
48
314
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
29
149
2.01
2.97
1.6
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
25
122
2.11
2.93
3.4
3.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
6
9
6.74
2.87
2.0
2.8
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
26
130
2.06
2.87
2.0
2.3
u/l
9757.5
2818.2
0.33
13
57
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
98
713
1.49
2.85
1.4
1.2
u/ml
0.7
1.6
0.83
33
199
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
5
6
8.41
2.75
1.2
1.0
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
36
205
1.83
2.75
2.7
2.8
e9/l
69.8
69.4
0.02
26
156
(3020717) Zinc [Moles/volume] in Serum or Plasma
7
14
5.06
2.74
2.0
1.0
umol/l
24.5
13.0
—
7
14
(3008401) Mugwort IgE Ab [Units/volume] in Serum
14
54
2.65
2.73
1.1
1.1
u/ml
0.4
3.7
—
9
26
(3003888) Timothy IgE Ab [Units/volume] in Serum
14
54
2.65
2.73
1.1
1.1
u/ml
6.4
11.6
—
9
30
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
34
191
1.85
2.71
1.1
1.3
iu/ml
311.2
138.0
0.86
13
78
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
10
32
3.18
2.66
1.0
1.2
—
—
—
0
0
(3019225) pH of Specimen
42
254
1.72
2.64
6.6
4.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
7
15
4.72
2.60
1.3
1.5
nmol/l
126.0
144.8
—
7
15
(3026389) Candida sp identified in Specimen by Organism specific culture
9
25
3.65
2.59
1.4
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
150
1.93
2.58
2.4
2.8
—
—
—
0
0
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
8
20
4.06
2.58
1.0
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
8
20
4.06
2.58
1.1
1.3
—
—
—
0
0
(3000991) Gas panel - Venous blood
40
242
1.72
2.51
3.5
8.7
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
25
130
1.98
2.51
2.8
4.1
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
58
387
1.58
2.50
1.4
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
7
16
4.43
2.48
1.0
1.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
7
16
4.43
2.48
1.1
1.3
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
39
236
1.72
2.45
3.1
2.7
g/l
9.2
10.7
1.53
33
222
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
18
83
2.22
2.44
1.5
2.0
g/l
2.7
3.0
0.85
12
66
(3042631) Mycobacterium sp identified in Specimen
10
34
2.99
2.42
2.9
2.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
14
58
2.46
2.39
2.1
1.4
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
8
6.31
2.38
1.0
1.1
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
5
8
6.31
2.38
1.6
1.5
umol/l
2.0
1.7
—
5
8
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
5
8
6.31
2.38
2.6
1.4
umol/l
27.0
28.1
—
5
8
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
9
28
3.26
2.32
1.4
1.8
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
10
35
2.90
2.32
2.6
2.6
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
274
2432
1.35
2.31
3.4
3.2
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
15
66
2.32
2.27
1.2
1.5
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
107
824
1.40
2.27
1.9
1.6
mmol/l
1.6
1.5
0.45
94
702
(3029937) Albumin [Presence] in Urine by Test strip
97
737
1.41
2.22
4.6
3.2
estimate
0.0
0.0
0.69
31
274
(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum
5
9
5.61
2.22
2.8
1.4
ug/l
39.6
69.8
—
5
9
(21494755) Public health laboratory ask at order entry panel
28
468
0.57
2.21
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
30
175
1.77
2.16
1.3
1.2
—
—
—
0
0
(3024263) Appearance of Synovial fluid
6
14
4.33
2.16
1.8
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
64
452
1.49
2.15
1.5
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
31
183
1.75
2.14
2.5
2.8
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
19
96
2.02
2.08
3.1
2.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
9
31
2.94
2.08
1.0
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
7
20
3.54
2.06
1.1
1.2
—
—
—
0
0
(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight
8
26
3.12
2.02
1.9
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
101
788
1.37
1.97
1.8
1.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
12
51
2.39
1.96
1.9
1.4
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
9
33
2.76
1.94
1.0
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
6
16
3.79
1.94
2.0
1.4
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
6
16
3.79
1.94
2.0
1.4
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
80
602
1.40
1.93
1.6
1.7
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
65
472
1.44
1.91
5.7
3.2
mmol/l
0.8
0.8
0.14
60
451
(3016018) Differential panel - Cerebral spinal fluid
8
28
2.89
1.87
1.0
1.2
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
11
46
2.43
1.86
1.3
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
21
115
1.87
1.86
1.1
1.4
miu/ml
195.1
269.2
—
9
54
(3000764) Benzodiazepines [Presence] in Urine
32
200
1.65
1.83
2.5
2.6
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
7
23
3.08
1.80
1.0
1.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
11
47
2.38
1.79
1.5
2.7
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
11
47
2.38
1.79
1.2
1.9
—
—
—
0
0
(3022145) Colonoscopy Study observation
48
333
1.50
1.77
1.4
1.4
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
32
203
1.62
1.74
2.5
2.6
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
32
203
1.62
1.74
2.7
2.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
17
89
1.95
1.72
2.2
2.6
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
67
499
1.41
1.72
2.9
2.8
mmol/l
2.4
2.4
0.12
55
446
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
11
48
2.33
1.72
1.9
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
20
112
1.82
1.67
1.7
1.7
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
30
190
1.62
1.65
3.1
2.7
e9/l
3.5
3.9
1.09
25
163
(3027944) Amphetamines [Presence] in Urine
31
198
1.61
1.65
2.6
2.5
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
18
98
1.87
1.64
1.3
1.2
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
16
84
1.94
1.62
3.2
3.9
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
43
298
1.49
1.61
1.4
1.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
15
77
1.98
1.61
1.3
1.4
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
18
99
1.85
1.59
1.5
1.6
iu/ml
0.1
0.1
—
5
18
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
20
3.03
1.58
1.0
1.2
—
—
—
0
0
(4027681)
6
20
3.03
1.58
1.3
1.3
—
—
—
0
0
(40768443) Skin Pathology biopsy report
20
115
1.78
1.55
1.2
1.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
20
115
1.78
1.55
3.1
3.4
g/l
0.5
0.2
—
10
49
(3004616) Nuclear Ab [Presence] in Serum
8
33
2.45
1.54
1.8
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
11
51
2.19
1.51
1.3
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
18
101
1.82
1.51
3.1
2.8
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
341
3203
1.31
1.49
14.6
10.5
ml/min/173m2
87.1
86.4
0.21
288
2592
(44790047)
9
38
2.40
1.46
2.6
1.5
—
—
—
0
0
(44806118)
9
38
2.40
1.46
2.6
1.5
—
—
—
0
0
(44790049)
9
38
2.40
1.46
2.6
1.5
—
—
—
0
0
(44790048)
9
38
2.40
1.46
2.6
1.5
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
7
28
2.52
1.45
1.3
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
13
66
2.00
1.45
1.8
1.3
ug/g
291.4
316.8
—
8
34
(40767503) Oxygen content in Capillary blood by calculation
10
46
2.20
1.41
1.6
2.7
%
16.4
16.8
—
5
28
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
8
163
0.48
1.39
2.0
1.9
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
9
42
2.17
1.34
1.3
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
9
43
2.12
1.31
1.7
1.5
—
—
—
0
0
(21494434) Karyotype in Bone marrow
6
24
2.52
1.31
1.0
1.2
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
10
48
2.11
1.28
1.3
1.2
u/l
17.9
11.9
—
10
42
(3027315) Oxygen [Partial pressure] in Blood
11
55
2.03
1.28
5.6
2.8
kpa
8.9
8.5
0.29
11
55
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
11
55
2.03
1.28
1.0
1.1
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
11
55
2.03
1.28
1.3
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
67
526
1.32
1.26
2.1
2.1
—
—
—
0
0
(3013290) Carbon dioxide [Partial pressure] in Blood
11
56
1.99
1.23
5.6
2.8
kpa
5.3
5.0
0.70
11
56
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
10
49
2.07
1.23
1.1
1.2
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
10
49
2.07
1.23
1.1
1.2
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
10
49
2.07
1.23
1.5
2.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
14
78
1.82
1.22
2.1
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
5
19
2.65
1.22
1.4
1.2
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
5
19
2.65
1.22
2.2
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
28
190
1.51
1.19
3.3
3.1
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
12
64
1.90
1.19
1.7
2.3
—
—
—
0
0
(1616796) Gas panel - Central venous blood
11
57
1.95
1.18
4.1
2.9
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
20
126
1.62
1.16
1.7
1.4
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
33
0.00
1.16
0.0
1.2
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
8
39
2.07
1.16
1.0
1.6
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
5
20
2.52
1.15
2.2
2.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
5
20
2.52
1.15
1.0
1.1
—
0.3
—
0
7
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
14
80
1.78
1.14
2.1
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
18
111
1.65
1.14
2.2
2.0
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
34
243
1.43
1.14
1.1
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
8
40
2.02
1.12
1.0
1.6
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
8
40
2.02
1.12
1.0
1.6
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
97
813
1.25
1.11
4.3
3.5
%
20.0
21.1
0.38
38
333
(3023410) Appearance of Cerebral spinal fluid
7
31
2.28
1.11
1.6
1.4
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
26
177
1.50
1.10
1.1
1.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
25
169
1.51
1.10
1.3
1.3
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
5
21
2.40
1.09
1.2
1.0
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
8
41
1.97
1.09
1.0
1.6
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
8
41
1.97
1.09
1.0
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
8
41
1.97
1.09
1.0
1.6
—
—
—
0
0
(1002224) Polysomnography panel
27
188
1.47
1.04
1.0
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
5
22
2.29
1.03
1.2
1.1
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
5
22
2.29
1.03
1.2
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
7
34
2.08
1.03
3.1
3.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
7
34
2.08
1.03
1.0
1.1
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
14
83
1.71
1.02
2.4
2.9
mg/l
9.3
12.8
1.32
14
77
(4094501)
14
83
1.71
1.02
1.1
1.1
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
10
53
1.91
1.02
2.9
2.7
e9/l
4.2
3.9
—
10
53
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
37
275
1.38
1.01
2.4
5.3
ug/l
4.5
24.5
0.69
29
222
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
30
216
1.42
0.98
1.7
2.4
ml/min/173m2
72.9
67.9
0.23
12
92
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
60
482
1.28
0.98
2.1
1.9
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
15
92
1.65
0.98
1.1
1.1
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
15
92
1.65
0.98
1.1
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
5
23
2.19
0.98
1.2
1.1
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
40
303
1.35
0.98
7.0
6.3
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
10
54
1.87
0.97
4.2
2.9
%
56.5
55.5
—
10
54
(42529406) Shigella sp [Presence] in Stool by Culture
15
93
1.64
0.95
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
6
27
2.24
0.94
1.0
1.3
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
140
1246
1.18
0.87
1.9
2.0
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
13
80
1.64
0.85
1.3
1.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
6
32
1.89
0.82
1.3
1.2
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
0
26
0.00
0.78
0.0
8.1
—
34.1
—
0
10
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
10
59
1.71
0.76
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
5
24
2.10
0.74
1.0
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
7
38
1.86
0.74
2.1
1.8
—
—
—
0
0
(4198724)
5
25
2.01
0.73
6.0
2.3
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
39
1.81
0.73
2.4
1.7
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
10
60
1.68
0.72
2.0
2.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
12
76
1.60
0.72
1.6
2.7
—
1.2
—
0
7
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
5
26
1.93
0.71
1.4
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
11
69
1.61
0.69
1.5
1.6
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
5
27
1.86
0.68
1.0
1.7
g/l
1.2
1.1
—
5
27
(3020891) Body temperature
15
102
1.49
0.68
3.3
4.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
22
162
1.38
0.67
2.1
1.5
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
5
28
1.79
0.66
23.0
9.4
mmol/l
0.5
0.6
—
5
28
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
5
28
1.79
0.66
4.0
4.6
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
49
406
1.23
0.66
1.7
1.7
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
13
188
0.68
0.64
1.3
1.5
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
15
104
1.46
0.63
2.1
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
31
245
1.29
0.61
4.0
3.3
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
48
402
1.22
0.59
1.7
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
32
256
1.27
0.58
2.0
1.9
—
—
—
0
0
(4034850)
13
89
1.48
0.58
6.6
7.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
6
36
1.68
0.57
1.0
1.9
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
34
276
1.25
0.56
3.6
2.6
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
9
60
1.51
0.54
1.4
3.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
43
361
1.21
0.53
1.8
1.8
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
10
66
1.53
0.53
1.2
1.1
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
63
1.44
0.52
1.3
1.1
—
14.2
—
0
6
(3017446) Testosterone [Moles/volume] in Serum or Plasma
40
334
1.22
0.52
2.7
2.1
nmol/l
14.1
14.4
0.09
35
314
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
92
1.43
0.51
1.3
1.6
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
35
289
1.23
0.51
1.9
2.0
u/l
29.5
196.8
0.52
28
252
(3042111) Morphology [Interpretation] in Bone marrow Narrative
7
46
1.53
0.48
1.1
1.5
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
7
47
1.50
0.47
1.0
1.1
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
7
48
1.47
0.47
1.0
1.1
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
7
49
1.44
0.46
1.1
2.1
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
7
49
1.44
0.46
1.6
2.9
u/ml
27.3
19.4
—
7
49
(3002256) Pathology report gross observation
45
387
1.18
0.45
1.2
1.3
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
7
51
1.38
0.44
1.0
1.1
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
8
56
1.44
0.42
1.4
1.6
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
5
32
1.57
0.42
1.0
2.1
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
8
58
1.39
0.41
1.6
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
5
34
1.48
0.40
1.2
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
10
137
0.72
0.39
1.1
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
10
136
0.73
0.38
2.0
2.4
u/ml
208.5
64.3
—
10
130
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
69
625
1.12
0.36
3.1
2.5
ug/l
0.5
0.8
4.66
42
357
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
5
79
0.63
0.36
1.2
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
88
954
0.90
0.35
1.4
1.5
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
6
45
1.34
0.34
1.0
1.1
—
—
—
0
0
(4306422)
7
52
1.35
0.31
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
24
203
1.19
0.30
2.0
1.9
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
7
54
1.30
0.30
1.3
1.1
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
10
75
1.34
0.30
1.1
2.0
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
24
279
0.85
0.28
1.5
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
8
64
1.25
0.27
1.9
1.5
—
—
—
0
0
(40768793) Breast Pathology biopsy report
8
67
1.20
0.26
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
13
106
1.23
0.23
1.8
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
7
93
0.75
0.22
1.4
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
10
79
1.27
0.22
1.5
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
17
199
0.85
0.22
1.5
1.6
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(4133840)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
11
90
1.23
0.19
1.1
1.1
—
—
—
0
0
(4035726)
24
267
0.89
0.17
1.2
1.4
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
37
399
0.92
0.15
1.6
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
35
378
0.92
0.15
3.8
3.8
%
28.8
31.4
0.66
27
249
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
9
83
1.09
0.14
1.6
1.7
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
138
1418
0.96
0.12
2.9
2.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
42
443
0.94
0.10
1.3
1.5
—
—
—
0
0
(4268621)
5
44
1.14
0.10
1.4
2.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
58
1.03
0.08
6.0
3.3
—
4142.2
—
0
6
(3002523) Influenza virus A Ag [Presence] in Specimen
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3003740) Influenza virus B Ag [Presence] in Specimen
5
60
0.83
0.08
1.0
1.1
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
8
94
0.85
0.06
2.0
1.6
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
14
135
1.04
0.00
1.4
1.2
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
16
156
1.03
0.00
4.8
10.9
mmol/l
24.8
24.3
0.39
16
149
(3005011) Chlamydia sp Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
7
73
0.96
0.00
1.6
1.2
nmol/l
1.0
0.8
—
7
61
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
57
0.88
0.00
1.0
2.7
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
9
96
0.94
0.00
1.1
1.6
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
0
8
0.00
0.00
0.0
3.1
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
6.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
4.9
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000213) Normetanephrine [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.4
—
1.9
—
0
5
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
0
9
0.00
0.00
0.0
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
0
6
0.00
0.00
0.0
4.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
3.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.8
—
8.9
—
0
6
(40768800) Prostate Pathology biopsy report
6
59
1.02
0.00
1.5
1.1
—
—
—
0
0
(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.0
—
10.2
—
0
6
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
7
0.00
0.00
0.0
4.3
—
3211.6
—
0
7
(3038177) Helicobacter pylori Ab [Presence] in Serum
5
54
0.93
0.00
1.0
1.1
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
5
55
0.91
0.00
1.6
1.2
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
8
87
0.92
0.00
1.3
1.2
—
—
—
0
0
(44806071)
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
0
5
0.00
0.00
0.0
2.0
—
0.4
—
0
5
(44816559) Phosphatidylethanol [Mass/volume] in Blood
8
89
0.90
0.00
1.1
1.3
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint M13_SPINALOSTEOCHON and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SPINALOSTEOCHON | 1.195 [1.02, 1.41] | 0.031 |
| Birth year | 0.994 [0.99, 1.0] | 0.182 |
During the follow-up period (1.1.1998 — 31.12.2019), 218 out of 1341 females with M13_SPINALOSTEOCHON died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| M13_SPINALOSTEOCHON | 1.222 [1.01, 1.48] | 0.041 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 212 out of 1938 males with M13_SPINALOSTEOCHON died.
Mortality risk
Mortality risk for people of age
years, who have M13_SPINALOSTEOCHON.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.115% | 0.219% |
| 5 | 0.877% | 1.405% |
| 10 | 1.929% | 3.729% |
| 15 | 3.596% | 6.762% |
| 20 | 6.181% | 11.273% |
Relationships between endpoints
↥Index endpoint: M13_SPINALOSTEOCHON – Spinal osteochondrosis
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data